Cargando…
lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
De novo and acquired resistance, largely attributed to genetic alterations, are barriers to effective anti-EGFR therapy. We generated cetuximab-resistant cells following prolonged cetuximab exposure to cetuximab-sensitive colorectal cancer cells in three-dimensional culture. Through whole exome sequ...
Autores principales: | Lu, Yuanyuan, Zhao, Xiaodi, Liu, Qi, Li, Cunxi, Graves-Deal, Ramona, Cao, Zheng, Singh, Bhuminder, Franklin, Jeffrey L., Wang, Jing, Hu, Huaying, Wei, Tianying, Yang, Mingli, Yeatman, Timothy J., Lee, Ethan, Saito-Diaz, Kenyi, Hinger, Scott, Patton, James G., Chung, Christine H., Emmrich, Stephan, Klusmann, Jan-Henning, Fan, Daiming, Coffey, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961502/ https://www.ncbi.nlm.nih.gov/pubmed/29035371 http://dx.doi.org/10.1038/nm.4424 |
Ejemplares similares
-
LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia
por: Emmrich, Stephan, et al.
Publicado: (2014) -
miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44
por: Sun, Lina, et al.
Publicado: (2019) -
miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
por: Kubota, Daisuke, et al.
Publicado: (2016) -
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
por: Vergani, Elisabetta, et al.
Publicado: (2015) -
Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
por: Torres, Anna, et al.
Publicado: (2012)